Athenex Moves Forward With $205M New York Plant Post author:Sam Post published:January 11, 2018 Post category:BioPharma According to a SEC filing, the cost of the facility will be paid in part by the State of New York. Source: BioSpace You Might Also Like What Biogen Wants in Return for Financial Assistance of Its $750,000 a Year Drug June 11, 2017 <b>SHYFT</b> Analytics Appoints <b>Joseph Tyers</b> To Chief Revenue Officer January 23, 2017 Poor Mid-Stage Results Sink AbbVie’s Plans for Cancer Drug March 21, 2018